tiprankstipranks
Cts Corp. (CTS)
NYSE:CTS
US Market
Want to see CTS full AI Analyst Report?

CTS (CTS) Earnings Dates, Call Summary & Reports

128 Followers

Earnings Data

Report Date
Jul 28, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
0.61
Last Year’s EPS
0.57
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 29, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call emphasized strong execution against the diversification strategy with broad-based revenue growth (notably in medical and industrial), margin expansion (250 bps YoY), improved profitability (adjusted EPS +~41% YoY), solid bookings/backlog (~$1.1B) and active capital returns. Headwinds include A&D booking timing, input-cost inflation (precious metals, resin, transportation), tariff/policy uncertainty, and geopolitical risks that could soften light-vehicle demand in H2. Management highlighted actions to mitigate cost pressures and a narrowed full-year guidance, indicating confidence but caution. Overall, positives (revenue, margin, bookings, cash returns, narrowed guidance) materially outweigh the manageable and outlined risks.
Company Guidance
Management narrowed full‑year 2026 guidance to sales of $560–$580 million and adjusted diluted EPS of $2.35–$2.45 (assuming current market conditions), with a full‑year tax rate expected at 21–23%; this follows Q1 results of $139 million in sales (up 11% YoY), adjusted diluted EPS of $0.62, adjusted gross margin of 39.5% (up 250 bps YoY), and overall book‑to‑bill of 1.1 (medical 1.2, industrial 1.29, A&D <1), with total booked business/backlog of about $1.1 billion. Management expects diversified end‑market demand to be solid (medical sales to grow double‑digits, industrial steady), transportation volumes to be slightly down overall (IHS: North America ~15M LV, Europe 16–17M, China ~32M) with commercial vehicle improvement in H2, and A&D bookings/funding to normalize in the second half. On the balance sheet and cash flow, Q1 generated $17M operating cash flow, cash of $91M, borrowings of $63M, $10M returned to shareholders year‑to‑date and ~$82M remaining on the repurchase authorization.
Revenue Growth
Q1 sales of $139 million, up 11% year-over-year and up 1% sequentially; diversified end markets sales up 18% and transportation sales up 3%.
Medical Market Outperformance
Medical sales of $25 million, up 28% YoY; medical bookings up 18% with a medical book-to-bill of 1.2; company expects continued double-digit medical sales growth and expanded capacity for therapeutic and aesthetics applications.
Industrial Momentum
Industrial sales of $37 million, up 14% YoY; industrial bookings up 28% and book-to-bill of 1.29 (vs 1.15 in 2025), driven by OEM and distribution recovery and wins across printing, flow meters, and temperature sensing.
Transportation Stability and Wins
Transportation sales of $60 million, up 3% YoY and 7% sequentially; multiple new business awards including current sensing and foot controls (Europe) and an accelerometer award (North American OEM); strengthening footwell and sensor portfolio.
Gross Margin Expansion
Adjusted gross margin of 39.5%, an improvement of 250 basis points YoY and +40 basis points sequentially, driven by operational improvements and favorable end-market mix.
Profitability Improvement
Adjusted diluted EPS of $0.62 in Q1 versus $0.44 prior year, an increase of ~41%; GAAP diluted EPS $0.59 versus $0.44 (~34% increase).
Strong Bookings and Backlog
Company-wide book-to-bill of 1.1 (up 4% vs 2025) and total booked business of approximately $1.1 billion at quarter end; strong bookings momentum in industrial and medical markets.
Large Defense Opportunity Win
Awarded a significant underwater hull penetrator win with a potential contract value of ~$20 million over five years and multiple naval sonar/filter wins; two new RF filter customers added.
Cash Generation and Capital Returns
Operating cash flow of $17 million YTD; cash balance $91 million; borrowings $63 million; returned $10 million to shareholders (dividends + buybacks) and repurchased ~177,000 shares (~$9 million); $82 million remaining on repurchase authorization.
Narrowed Full-Year Guidance
Full-year 2026 sales guidance narrowed to $560M–$580M and adjusted diluted EPS guidance narrowed to $2.35–$2.45, reflecting confidence in outlook assuming market continuity.

CTS (CTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 28, 2026
2026 (Q2)
0.61 / -
0.57
Apr 29, 2026
2026 (Q1)
0.52 / 0.62
0.4440.91% (+0.18)
Feb 10, 2026
2025 (Q4)
0.60 / 0.62
0.5316.98% (+0.09)
Oct 28, 2025
2025 (Q3)
0.61 / 0.60
0.63-4.76% (-0.03)
Jul 24, 2025
2025 (Q2)
0.55 / 0.57
0.545.56% (+0.03)
Apr 30, 2025
2025 (Q1)
0.49 / 0.44
0.47-6.38% (-0.03)
Feb 04, 2025
2024 (Q4)
0.54 / 0.53
0.4712.77% (+0.06)
Oct 29, 2024
2024 (Q3)
0.54 / 0.63
0.5416.67% (+0.09)
Jul 30, 2024
2024 (Q2)
0.53 / 0.54
0.59-8.47% (-0.05)
May 01, 2024
2024 (Q1)
0.41 / 0.47
0.61-22.95% (-0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2026
$54.27$54.43+0.29%
Feb 10, 2026
$55.53$57.24+3.08%
Oct 28, 2025
$42.37$40.44-4.55%
Jul 24, 2025
$40.33$41.88+3.86%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cts Corp. (CTS) report earnings?
Cts Corp. (CTS) is schdueled to report earning on Jul 28, 2026, Before Open (Confirmed).
    What is Cts Corp. (CTS) earnings time?
    Cts Corp. (CTS) earnings time is at Jul 28, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CTS EPS forecast?
          CTS EPS forecast for the fiscal quarter 2026 (Q2) is 0.61.